Find Faculty Members at MUSC.

Nathan Dolloff PhD

Nathan Graeme Dolloff PhD

Provider Image
Rank
  • Associate Professor
College
  • College of Medicine
Department
  • Pharmacology & Immunology
Academic Focus
  • Experimental cancer therapeutics
  • High throughput drug screening (HTS)
  • Academic drug discovery
Faculty email addresses should not be used to seek medical advice or to make medical appointments. Please visit MyChart for medical appointments or to contact your provider.

Locations

Office Location
street
room

Biography

Nathan Dolloff is the Chief Technology Officer for the Zucker Institute for Innovation Commercialization and leads the Biopharma technology vertical. Nathan is a scientist by training and faculty member at MUSC, where he leads a cancer drug discovery program that has been funded by the NCI since 2013. He is experienced in academic entrepreneurship as an inventor and founder of Leukogene Therapeutics Inc., a growing South Carolina cancer therapeutics company. Dolloff has led entrepreneurship efforts at the Hollings Cancer Center and MUSC Office of Innovation since 2021. In his role as ZI CTO, he supports the technology commercialization continuum from intellectual property evaluation and prioritization to entrepreneurship mentoring and licensing partner outreach and engagement. Dolloff was born in Pennsylvania where he did his graduate and postdoctoral training in Philadelphia at Drexel College of Medicine and the University of Pennsylvania prior to moving to South Carolina in 2014.